Neurotransmisión y neurorreparación
Università degli Studi di Siena
Siena, ItaliaPublicacións en colaboración con investigadores/as de Università degli Studi di Siena (7)
2020
-
The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis
Apoptosis, Vol. 25, Núm. 9-10, pp. 674-685
2017
-
Comparative Analysis of the Neurochemical Profile and MAO Inhibition Properties of N-(Furan-2-ylmethyl)-N-methylprop-2-yn-1-amine
ACS Chemical Neuroscience, Vol. 8, Núm. 5, pp. 1026-1035
-
Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease
Progress in Neurobiology, Vol. 151, pp. 4-34
2016
-
Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation
European Journal of Medicinal Chemistry, Vol. 121, pp. 864-879
2015
-
Development of HuperTacrines as non-toxic, cholinesterase inhibitors for the potential treatment of Alzheimer’s disease
Mini-Reviews in Medicinal Chemistry, Vol. 15, Núm. 8, pp. 648-658
2008
-
Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5- benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells
Journal of Neurochemistry, Vol. 105, Núm. 6, pp. 2404-2417
2007
-
CYP-dependent metabolism of PF9601N, a new monoamine oxidase-B inhibitor, by C57BL/6 mouse and human liver microsomes.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques, Vol. 10, Núm. 4, pp. 473-485